絞り込み

16644

広告

Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes risk.

著者 Greenwald WW , Chiou J , Yan J , Qiu Y , Dai N , Wang A , Nariai N , Aylward A , Han JY , Kadakia N , Regue L , Okino ML , Drees F , Kramer D , Vinckier N , Minichiello L , Gorkin D , Avruch J , Frazer KA , Sander M , Ren B , Gaulton KJ
Nat Commun.2019 May 07 ; 10(1):2078.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (4view , 0users)

Full Text Sources

Medical

Miscellaneous

Molecular Biology Databases

Genetic variants affecting pancreatic islet enhancers are central to T2D risk, but the gene targets of islet enhancer activity are largely unknown. We generate a high-resolution map of islet chromatin loops using Hi-C assays in three islet samples and use loops to annotate target genes of islet enhancers defined using ATAC-seq and published ChIP-seq data. We identify candidate target genes for thousands of islet enhancers, and find that enhancer looping is correlated with islet-specific gene expression. We fine-map T2D risk variants affecting islet enhancers, and find that candidate target genes of these variants defined using chromatin looping and eQTL mapping are enriched in protein transport and secretion pathways. At IGF2BP2, a fine-mapped T2D variant reduces islet enhancer activity and IGF2BP2 expression, and conditional inactivation of IGF2BP2 in mouse islets impairs glucose-stimulated insulin secretion. Our findings provide a resource for studying islet enhancer function and identifying genes involved in T2D risk.
PMID: 31064983 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード